Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana

INTRODUCTION: Despite declining risk of vertical HIV transmission, prophylactic cotrimoxazole (CTX) remains widely used to reduce morbidity and mortality in the event of HIV infection among exposed infants, with an inherent risk of conferring commensal antimicrobial resistance. Using data from a ran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Int AIDS Soc
Autores principales: Powis, Kathleen M, Souda, Sajini, Lockman, Shahin, Ajibola, Gbolahan, Bennett, Kara, Leidner, Jean, Hughes, Michael D, Moyo, Sikhulile, van Widenfelt, Erik, Jibril, Haruna B, Makhema, Joseph, Essex, Max, Shapiro, Roger L
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2017
Materias:
Short Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5810322/
https://ncbi.nlm.nih.gov/pubmed/29119726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares